RETLIRAFUSP ALFA
UNII JP6N6TA92L

Substance Identification & Data

This profile provides standardized clinical and technical data for Retlirafusp Alfa, uniquely identified by the FDA Unique Ingredient Identifier (UNII) JP6N6TA92L.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2395839-91-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

JP6N6TA92L

CAS Registry Number

2395839-91-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

RETLIRAFUSP ALFA

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C178398

National Cancer Institute reference terminology for clinical and research data.

INN ID

11662

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Retlirafusp Alfa. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

RETLIRAFUSP ALFA

Common Names & Synonyms

IMMUNOGLOBULIN G4 (52-GLYCINE, 57-PHENYLALANINE, 227-PROLINE, 233-ALANINE, 234-ALANINE, 446-ALANINE), ANTI-(HUMAN PROGRAMMED DEATH-LIGAND 1) (HUMAN-MUS MUSCULUS MONOCLONAL SHR-1316 .GAMMA.4-CHAIN) FUSION PROTEIN WITH PEPTIDE LINKER ((GGGGS)4G) FUSION PROTEIN WITH 20-136-TYPE II TRANSFORMING GROWTH FACTOR .BETA. RECEPTOR (HUMAN ISOFORM 1), DISULFIDE WITH (85-GLUTAMIC ACID) HUMAN-MUS MUSCULUS MONOCLONAL SHR-1316 .KAPPA.-CHAIN, DIMER

RETLIRAFUSP ALFA [INN]

RETLIRAFUSP ALFA [WHO-DD]